Staining for LMP1, which is positive in most EBV+ DLBCL, highlights the variability of the EBV+ tumor cells, as well as the variability in LMP1 staining, whereas EBV+ CHL exhibits homogenous expression of LMP1 in the HRS cells. This evidence concerns the gene PDLIM7 and neoplasm.